Publications Acknowledging the Core
1. Muhammad AK, Puntel M, Candolfi M, Salem A, Yagiz K, Farrokhi C, Kroeger KM, Xiong W, Curtin JF, Liu C, Lawrence K, Bondale NS, Lerner J, Baker GJ, Foulad D, Pechnick RN, Palmer D, Ng P, Lowenstein PR, Castro MG (2009). Efficacy, biodistribution and safety profile of therapeutic gutless adenovirusvectors as a prelude to a Phase I Clinical Trial for Glioblastoma. Clinical Pharmacology and Therapeutics (In press)2. Candolfi M, Kroeger KM, Muhammad AK, Yagiz K, Farrokhi C, Pechnick RN,
Lowenstein PR, Castro MG. Gene therapy for brain cancer: combination therapies
provide enhanced efficacy and safety. Curr Gene Ther. 2009 Oct;9(5):409-21.
